蒲公英 - 制药技术的传播者 GMP理论的实践者

搜索
查看: 1064|回复: 6
收起左侧

[行业动态] 印度对中国的氧氟沙星进口实施反倾销关税

[复制链接]
药士
发表于 2018-3-18 23:38:06 | 显示全部楼层 |阅读模式

欢迎您注册蒲公英

您需要 登录 才可以下载或查看,没有帐号?立即注册

x
Anti-dumping duty imposed on Ofloxacin import from China

Pharmaceuticals-Healthcare/Biotech-Industry-The Economic Times / 2018-03-18 14:47

NEW DELHI: India has imposed anti-dumping duty on import of Chinese pharma product, used in treatment of certain infections, to protect domestic producers from below-cost shipments.
The duty on import of 'Ofloxacin' from China will be in the range of USD 2.58 to USD 9.48 per kilogram for three years, said a notification issued by the revenue department in the finance ministry.

The levy has been slapped following the recommendations of the Directorate General of Anti-Dumping and Allied Duties (DGAD).

Aarti Drugs had approached the DGAD for initiation of anti-dumping investigation and imposition of the duty concerning imports of Ofloxacin, originating in or exported from China.

After a probe into the imports, the Authority concluded that the product has been exported to India from China below its normal value, "resulting in dumping".

"The domestic industry has suffered material injury due to dumping of the product...," the DGAD said while recommending the levy.

Ofloxacin is used to treat certain infections including bronchitis, pneumonia and infections of the skin, bladder, urinary tract, reproductive organs, and prostate (a male reproductive gland).

Ofloxacin is in a class of antibiotics called fluoroquinolones. It works by killing bacteria that cause infections.

Countries carry out anti-dumping probe to determine whether their domestic industries have been hurt because of a surge in imports which are below the cost of producing them.

As a counter measure, they impose duties under the multilateral regime of WTO.

The duty is aimed at ensuring fair trading practises and creating a level-playing field for domestic producers with regard to foreign producers and exporters.


回复

使用道具 举报

药士
发表于 2018-3-18 23:51:17 | 显示全部楼层
印度阿三,胆儿真肥。
回复

使用道具 举报

药士
 楼主| 发表于 2018-3-18 23:57:39 | 显示全部楼层
现在的国际大形势对于中国还是不力啊,美国,印度,欧洲一个一个的来!
回复

使用道具 举报

药生
发表于 2018-3-19 08:44:09 | 显示全部楼层
大不了不出口,自己用。
回复

使用道具 举报

药徒
发表于 2018-3-19 09:08:58 | 显示全部楼层
竞争太激烈,这个明显属于贸易保护主义。
回复

使用道具 举报

药生
发表于 2018-3-19 09:19:05 | 显示全部楼层
印度人真是毛病
回复

使用道具 举报

药徒
发表于 2018-3-19 10:34:56 | 显示全部楼层
阿三也跳起来了。HETERO,LUPIN,SEQUENT 和 BAJAJ 哪个不是像个狗一样,不理他,他就乖乖的
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

×发帖声明
1、本站为技术交流论坛,发帖的内容具有互动属性。您在本站发布的内容:
①在无人回复的情况下,可以通过自助删帖功能随时删除(自助删帖功能关闭期间,可以联系管理员微信:8542508 处理。)
②在有人回复和讨论的情况下,主题帖和回复内容已构成一个不可分割的整体,您将不能直接删除该帖。
2、禁止发布任何涉政、涉黄赌毒及其他违反国家相关法律、法规、及本站版规的内容,详情请参阅《蒲公英论坛总版规》。
3、您在本站发表、转载的任何作品仅代表您个人观点,不代表本站观点。不要盗用有版权要求的作品,转贴请注明来源,否则文责自负。
4、请认真阅读上述条款,您发帖即代表接受上述条款。

QQ|手机版|蒲公英|ouryao|蒲公英 ( 京ICP备14042168号-1 )  增值电信业务经营许可证编号:京B2-20243455  互联网药品信息服务资格证书编号:(京)-非经营性-2024-0033

GMT+8, 2025-9-10 19:54

Powered by Discuz! X3.4

Copyright © 2001-2020, Tencent Cloud.

声明:蒲公英网站所涉及的原创文章、文字内容、视频图片及首发资料,版权归作者及蒲公英网站所有,转载要在显著位置标明来源“蒲公英”;禁止任何形式的商业用途。违反上述声明的,本站及作者将追究法律责任。
快速回复 返回顶部 返回列表